Home International First GLP-1 pills for weight loss go on sale in Australia

First GLP-1 pills for weight loss go on sale in Australia

0
6
Advertisement
Rachel Rasker

Australians can access the first GLP-1 pills for weight loss through private prescription from Friday, likely boosting sales of the popular drugs already used by more than half a million people here.

Glucagon-like peptide-1 receptor agonists, or GLP-1s, were previously only available through a weekly injection, while the new Wegovy and Foundayo pills are taken as daily oral tablets.

Wegovy has landed on shelves across Australia.Louise Kennerley

Millions of Australians are expected to use GLP-1s in the coming years, with the drugs boasting powerful health effects including significant weight loss, improved blood glucose control and other metabolic health benefits.

However, experts have warned there is a lack of research into the wider effects of the medications, including the risk of malnutrition, which can cause serious health concerns but go unnoticed as symptoms of nutrient deficiency mimic the side effects of GLP-1s, including fatigue, nausea, diarrhoea and constipation.

Advertisement

The medications work by curbing appetite, slowing digestion and promoting feelings of fullness.

The Wegovy pill, manufactured by Novo Nordisk, was approved by the TGA earlier this month.

It’s taken every morning on an empty stomach and stays stable at room temperature, unlike the injectable Wegovy, which requires refrigeration.

The new tablet’s pricing will vary by dose, ranging from about $260 per month for a 1.5mg tablet to $395 a month for 25mg. For patients on the lower doses, this works out at less than $10 a day.

The pill is cheaper than the injectable, which costs between $350 and $500 per month.

Advertisement

The new tablets are available on shelves from Friday, Novo Nordisk confirmed.

Competing manufacturer Lilly won approval for its rival pill Foundayo on Monday, promising availability “in the coming days”.

However, while doctors could prescribe the drug from the day of approval, stocks are yet to arrive in pharmacies.

Foundayo is a small-molecule, non-peptide GLP-1 receptor agonist taken as a daily pill at any time, without food or water restrictions.

Advertisement

It is expected to cost between $250 and $370 per month, depending on the dose and the pharmacy.

Users need to be prescribed the pills by their doctor, which may also require an out-of-pocket cost.

The Australian government is facing growing pressure to add GLP-1s to the Pharmaceutical Benefits Scheme for weight loss.

The high price point of the medicines mean they remain out of reach for many with obesity, which disproportionately affects low and middle-income individuals.

Start the day with a summary of the day’s most important and interesting stories, analysis and insights. Sign up for our Morning Edition newsletter.

From our partners

Advertisement
Advertisement

Disclaimer : This story is auto aggregated by a computer programme and has not been created or edited by DOWNTHENEWS. Publisher: www.smh.com.au